Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian CROs Move Up R&D Value Chain From Outsourcing Services To Partnering With MNCs

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - India, along with China, is increasingly becoming a popular destination for pharmaceutical research and development outsourced from the West, and more multinational companies are partnering with Indian CROs to improve productivity, cut costs and bring more drugs to market faster

You may also be interested in...



India’s Expanding Middle Class To Drive Pharma Industry Annual Growth to 20 Percent By 2015

NEW DELHI - India's pharmaceutical industry is forecast to grow by nearly 20 percent annually by 2015, spurred by rising incomes and better health awareness, according to a study commissioned by Indian industry lobby group the Confederation of Indian Industry

India’s Expanding Middle Class To Drive Pharma Industry Annual Growth to 20 Percent By 2015

NEW DELHI - India's pharmaceutical industry is forecast to grow by nearly 20 percent annually by 2015, spurred by rising incomes and better health awareness, according to a study commissioned by Indian industry lobby group the Confederation of Indian Industry

A Tale Of Two Giants; Tracking India And China’s Rise In The Pharmaceutical Market

SHANGHAI - The nature of business relationships between multinational pharma companies and Indian and Chinese firms varies significantly, according to a recent study released by the Ewing Marion Kauffman Foundation

Related Content

UsernamePublicRestriction

Register

PS140995

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel